Gland Pharma Schedules One-on-One Meeting with Kotak Mutual Fund
Gland Pharma Ltd 路 Intimation 路 04 Sept 2026, 8:24 pm
Gland Pharma Schedules One-on-One Meeting with Kotak Mutual Fund Gland Pharma Limited has scheduled a one-on-one meeting with Kotak Mutual Fund on 9th Sep'26, pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The schedule remains subject to changes arising from any exigencies on the part of the fund, analyst, or the company.
Original exchange filing (PDF)
More announcements from Gland Pharma Ltd
- Schedule of Investor Meet Intimation 路 17 Nov 2026
- Allotment of 3739 Equity Shares on exercise of ESOPs 路 16 Nov 2026
- Grant of Options to Purchase Securities 路 16 Nov 2026
- Q2FY27 Earnings Call Transcript 路 12 Nov 2026
- Gland Pharma Limited has issued Corporate Guarantee on behalf of Phixen SAS, wholly owned step down subsidiary of the Company 路 12 Nov 2026
- Appointment of Mr. Xiao Le as Chief Investment Officer at Gland Pharma International Pte. Ltd, wholly owned subsidiary of Gland Pharma Limited, effective November 09, 2026 路 09 Nov 2026
- Q2FY27 Earnings Call Recording 路 07 Nov 2026
- Q2Fy27 Investors presentation 路 06 Nov 2026
